FIELD: medicine.
SUBSTANCE: invention describes a method for prediction of a recurrent vulvar cancer involving biochemical blood count; the check-up examination of the patients suffering from vulvar cancer are used to determine a protein absorption by lipid matrix of red blood cell membrane; and if the derived value is within the range of 0.21-0.35, the recurrences are predicted, and the value of 0.08-0.2 shows the long-term remission.
EFFECT: method enables predicting recurrent vulvar cancer individually for each patient before the clinical manifestations by using biochemical blood count that provides the timely antineoplastic therapy and promotes the long-length and higher quality of life of the patients suffering from vulvar cancer.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REMISSION DURATION PREDICTION IN PATIENTS WITH VULVA CANCER | 2016 |
|
RU2624508C1 |
| METHOD FOR PREDICTING COURSE OF TUMOUR PROCESS IN PATIENTS WITH VULVAR CANCER | 2015 |
|
RU2613119C1 |
| METHOD OF PREDICTION OF RECURRENT VULVAR CANCER I AND II STAGE | 2015 |
|
RU2608508C1 |
| PROGNOSIS OF TREATMENT EFFECTIVENESS FOR III-IV-STEP BREAST CANCER PATIENTS | 2003 |
|
RU2254576C2 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD FOR PREDICTING GENERALIZATION OF MAMMARY CANCER | 2001 |
|
RU2204836C2 |
| METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD FOR PREDICTING VULVA CANCER TREATMENT RESULTS | 1998 |
|
RU2153175C1 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
